Transmission electron microscopy image of L. pneumophila, responsible for over 90% of Legionnaires' disease cases
|Classification and external resources|
|Specialty||Infectious disease, pulmonology|
Legionnaires' disease, also known as legionellosis or Legion fever, is a form of atypical pneumonia caused by any type of Legionella bacteria. Over 90% of cases of Legionnaires' disease are caused by Legionella pneumophila.
Other causative species include L. longbeachae, L. feeleii, L. micdadei and L. anisa. These species cause a less severe infection known as Pontiac fever, which resembles acute influenza. These bacterial species can be water-borne or present in soil, whereas L. pneumophila has only been found in aquatic systems, where it is symbiotically present in aquatic-borne amoebae. It thrives in temperatures between 25 and 45 °C (77 and 113 °F), with an optimum temperature of 35 °C (95 °F). During infection, the bacterium invades macrophages and lung epithelial cells and replicates intracellularly.
Signs and symptoms
The length of time between exposure to the bacteria and the appearance of symptoms in Legionnaires' disease is generally 2 to 10 days, and, rarely, can be up to 20 days. For the general population, among those exposed between 0.1 to 5% develop disease, while among those in hospital between 0.4 to 14% develop disease.
Those with Legionnaires' disease usually have fever, chills, and a cough, which may be dry or may produce sputum. Almost all with Legionnaires' experience fever, while approximately half have cough with sputum, and one third cough up blood or bloody sputum. Some also have muscle aches, headache, tiredness, loss of appetite, loss of coordination (ataxia), chest pain, or diarrhea and vomiting. Up to half of those with Legionnaires' have gastrointestinal symptoms, and almost half have neurological symptoms, including confusion and impaired cognition. "Relative bradycardia" may also be present, which is low or low-normal heart rate despite the presence of a fever.
Laboratory tests may show that kidney functions, liver functions and electrolyte levels are abnormal, which may include low sodium in the blood. Chest X-rays often show pneumonia with bi-basilar consolidation. It is difficult to distinguish Legionnaires' disease from other types of pneumonia by symptoms or radiologic findings alone; other tests are required for diagnosis.
Persons with Pontiac fever experience fever and muscle aches without pneumonia. They generally recover in two to five days without treatment. For Pontiac fever the time between exposure and symptoms is generally a few hours to two days.
Legionnaires' disease is transmitted by inhalation of aerosolized water and/or soil contaminated with the Legionella bacteria. It is not airborne and Legionnaires' disease is not transmitted from person to person. Rarely, Legionnaires' disease has been transmitted by direct contact between contaminated water and surgical wounds. It thrives at water temperatures between 25 and 42 °C (77 and 117 °F), with an optimum temperature of 35 °C (95 °F). Sources where temperatures allow the bacteria to thrive include hot-water tanks, cooling towers, and evaporative condensers of large air-conditioning systems, such as those commonly found in hotels and large office buildings. Though the first known outbreak was in Philadelphia, Pennsylvania, cases of legionellosis have occurred throughout the world.
L. pneumophila thrives in aquatic systems where it is established within amoebae in a symbiotic relationship. In the built environment, central air conditioning systems in office buildings, hotels, and hospitals are sources of contaminated water. Other places it can dwell include cooling towers used in industrial cooling systems, evaporative coolers, nebulizers, humidifiers, whirlpool spas, water heating systems, showers, windshield washers, fountains, room-air humidifiers, ice-making machines, and misting systems typically found in grocery-store produce sections.
The disease may also be transmitted from contaminated aerosols generated in hot tubs if the disinfection and maintenance program is not followed rigorously. Freshwater ponds, creeks, and ornamental fountains are potential sources of Legionella. The disease is particularly associated with hotels, fountains, cruise ships, and hospitals with complex potable water systems and cooling systems. Respiratory care devices such as humidifiers and nebulizers used with contaminated tap water may contain Legionella species, so using sterile water is very important. Other sources include exposure to potting mix and compost.
Legionella bacteria survive in water as intracellular parasites of water-dwelling protozoae, such as amoebae. Amoebae are often part of biofilms, and once Legionella and infected amoebae are protected within a biofilm, they are particularly difficult to destroy.
Legionella enters the lung either by aspiration of contaminated water or inhalation of aerosolized contaminated water or soil. There, the bacteria is phagocytized by macrophages, a type of white blood cell, where it multiplies, causes the death of the macrophage, at which point the bacteria are released from the dead cell to infect other macrophages. Virulent strains of Legionella kill macrophages by blocking the fusion of phagosomes with lysosomes inside the host cell; normally the bacteria is contained inside the phagosome, which merges with a lysosome, allowing enzymes and other chemicals to break down the invading bacteria.
People of any age may suffer from Legionnaires' disease, but the illness most often affects middle-aged and older persons, particularly those who smoke cigarettes or have chronic lung disease. Immunocompromised people are also at elevated risk. Pontiac fever most commonly occurs in persons who are otherwise healthy.
The most useful diagnostic tests detect the bacteria in sputum, find Legionella antigens in urine samples, or allow comparison of Legionella antibody levels in two blood samples taken 3 to 6 weeks apart. A urine antigen test is simple, quick, and very reliable, but it will only detect Legionella pneumophila serogroup 1, which accounts for 70 percent of disease caused by L. pneumophila which means use of the urine antigen test alone may miss as many as 40% of cases. This test was developed by Richard Kohler in 1982. When dealing with Legionella pneumophila serogroup 1, the urine antigen test is useful for early detection of Legionnaire's disease and initiation of treatment, and has been helpful in early detection of outbreaks. However, it will not identify the specific subtypes, so it cannot be used to match the person with the environmental source of infection. The Legionella bacteria can be cultured from sputum or other respiratory samples.Legionella stains poorly with Gram stain, stains positive with silver, and is cultured on charcoal yeast extract with iron and cysteine (CYE agar).
A significant under-reporting problem occurs with legionellosis. Even in countries with effective health services and readily available diagnostic testing, about 90 percent of cases of Legionnaires' disease are missed. This is partly due to Legionnaire's disease being a relatively rare form of pneumonia, which many clinicians may not have encountered before and thus may misdiagnose. A further issue is that people with legionellosis can present with a wide range of symptoms, some of which (such as diarrhea) may distract clinicians from making a correct diagnosis.
Effective medications include most macrolides, tetracyclines, ketolides, and quinolones. Legionella multiply within the cell, so any effective treatment must have excellent intracellular penetration. Current treatments of choice are the respiratory tract quinolones (levofloxacin, moxifloxacin, gemifloxacin) or newer macrolides (azithromycin, clarithromycin, roxithromycin). The antibiotics used most frequently have been levofloxacin, doxycycline and azithromycin.
Macrolides (azithromycin) are used in all age groups, while tetracyclines (doxycycline) are prescribed for children above the age of 12 and quinolones (levofloxacin) above the age of 18. Rifampicin can be used in combination with a quinolone or macrolide. It is uncertain whether rifampicin is an effective antibiotic to take for treatment. The Infectious Diseases Society of America does not recommend the use of rifampicin with added regimens. Tetracyclines and erythromycin led to improved outcomes compared to other antibiotics in the original American Legion outbreak. These antibiotics are effective because they have excellent intracellular penetration in Legionella-infected cells. The recommended treatment is 5–10 days of levofloxacin or 3–5 days of azithromycin, but in people who are immunocompromised, have severe disease, or other pre-existing health conditions, longer antibiotic use may be necessary. During outbreaks, prophylactic antibiotics have been successfully used to prevent Legionnaires' disease in high-risk individuals who have possibly been exposed.
The mortality at the original American Legion convention in 1976 was high (34 deaths in 180 infected individuals) because the antibiotics used (including penicillins, cephalosporins, and aminoglycosides) had poor intracellular penetration. Mortality has plunged to less than 5% if therapy is started quickly. Delay in giving the appropriate antibiotic leads to higher mortality.
The fatality rate of Legionnaires' disease has ranged from 5% to 30% during various outbreaks and approaches 50% for nosocomial infections, especially when treatment with antibiotics is delayed. According to the journal Infection Control and Hospital Epidemiology, hospital-acquired Legionella pneumonia has a fatality rate of 28%, and the principal source of infection in such cases is the drinking-water distribution system.
Legionnaires' disease acquired its name in July 1976, when an outbreak of pneumonia occurred among people attending a convention of the American Legion at the Bellevue-Stratford Hotel in Philadelphia. Of the 182 reported cases, mostly men, 29 died. On January 18, 1977, the causative agent was identified as a previously unknown strain of bacteria, subsequently named Legionella, and the species that caused the outbreak was named Legionella pneumophila.
Outbreaks of Legionnaires' disease receive significant media attention. However, this disease usually occurs in single, isolated cases not associated with any recognized outbreak. When outbreaks do occur, they are usually in the summer and early autumn, though cases may occur at any time of year. Most infections occur in those who are middle-aged or older. National surveillance systems and research studies were established early, and in recent years[when?] improved ascertainment and changes in clinical methods of diagnosis have contributed to an upsurge in reported cases in many countries. Environmental studies continue to identify novel sources of infection, leading to regular revisions of guidelines and regulations. About 8,000 to 18,000 cases of Legionnaires' disease occur each year in the United States, according to the Bureau of Communicable Disease Control.
Between 1995 and 2005, over 32,000 cases of Legionnaires' disease and more than 600 outbreaks were reported to the European Working Group for Legionella Infections The data on Legionella are limited in developing countries and Legionella-related illnesses likely are underdiagnosed worldwide. Improvements in diagnosis and surveillance in developing countries would be expected to reveal far higher levels of morbidity and mortality than are currently recognised. Similarly, improved diagnosis of human illness related to Legionella species and serogroups other than Legionella pneumophila would improve knowledge about their incidence and spread.
A 2011 study successfully used modeling to predict the likely number of cases during Legionnaires’ outbreaks based on symptom onset dates from past outbreaks. In this way, the eventual likely size of an outbreak can be predicted, enabling efficient and effective use of public health resources in managing an outbreak.
The first recognized cases of Legionnaires' disease occurred in 1976 in Philadelphia, Pennsylvania. Among more than 2000 attendees of a Legionnaires' convention held at the Bellevue-Stratford Hotel, 221 attendees contracted the disease and 34 of them died.
In April 1985, 175 people were admitted to the District or Kingsmead Stafford Hospitals with chest infection or pneumonia. A total of 28 people died. Medical diagnosis showed that Legionnaires' disease was responsible and the immediate epidemiological investigation traced the source of the infection to the air-conditioning cooling tower on the roof of Stafford District Hospital.
In March 1999, a large outbreak in the Netherlands occurred during the Westfriese Flora flower exhibition in Bovenkarspel; 318 people became ill and at least 32 people died. This was the second-deadliest outbreak since the 1976 outbreak and possibly the deadliest as several people were buried before Legionnaires' disease had been diagnosed.
The world's largest outbreak of Legionnaires' disease happened in July 2001 with people appearing at the hospital on July 7, in Murcia, Spain. More than 800 suspected cases were recorded by the time the last case was treated on July 22; 636–696 of these cases were estimated and 449 confirmed (so, at least 16,000 people were exposed to the bacterium) and six died, a case-fatality rate around 1%.
In late September 2005, 127 residents of a nursing home in Canada became ill with L. pneumophila. Within a week, 21 of the residents had died. Culture results at first were negative, which is not unusual, as L. pneumophila is a fastidious bacterium, meaning it requires specific nutrients and/or living conditions in order to grow. The source of the outbreak was traced to the air-conditioning cooling towers on the nursing home's roof.
As of 12 November 2014, 302 people have been hospitalized following an outbreak of Legionella in Portugal and 7 related deaths have been reported. All cases, so far, have emerged in three civil parishes from the municipality of Vila Franca de Xira in the northern outskirts of Lisbon, Portugal and are being treated in hospitals of the Greater Lisbon area. The source is suspected to be located in the cooling towers of the fertilizer plant Fertibéria.
As of 10 August 2015, there have been over 110 confirmed cases and 12 deaths from the 2015 New York Legionnaires' disease outbreak in the New York City borough of the Bronx. City health inspectors identified Legionella in the cooling systems of five public places: a hotel, Concourse Plaza Mall, a Verizon office, the Streamline Plastic Company, and at a building in the Lincoln Hospital complex. All of these places have since been decontaminated, according to the city.
- Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN 0-8385-8529-9.
- Winiecka-Krusnell J, Linder E (1999). "Free-living amoebae protecting Legionella in water: The tip of an iceberg?". Scandinavian journal of infectious diseases 31 (4): 383–385. doi:10.1080/00365549950163833. PMID 10528878.
- Takamatsu R, Teruya H, Takeshima E, Ishikawa C, Matsumoto K, Mukaida N, Li JD, Heuner K, Higa F, Fujita J, Mori N (2010). "Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells". BMC Microbiology 10: 1. doi:10.1186/1471-2180-10-1. PMC 2824691. PMID 20051107.
- Swanson M, Heuner K (2008). Legionella: Molecular Microbiology. Caister Academic Pr. ISBN 1-904455-26-3.
- Legionella and the prevention of legionellosis (PDF). Geneva: World Health Organization. 2007. ISBN 9241562978.
- Cunha, Burke A; Burillo, Almudena; Bouza, Emilio (2015). "Legionnaires' disease". The Lancet. doi:10.1016/S0140-6736(15)60078-2. ISSN 0140-6736.
- Edelstein PH. Legionnaires Disease: History and clinical findings. Open Access Biology http://www.open-access-biology.com/legionella/edelstein.html
- Ostergaard L, Huniche B, Andersen PL (November 1996). "Relative bradycardia in infectious diseases". J. Infect. 33 (3): 185–91. doi:10.1016/S0163-4453(96)92225-2. PMID 8945708.
- Fields, B. S.; Benson, R. F.; Besser, R. E. (2002). "Legionella and Legionnaires' Disease: 25 Years of Investigation". Clinical Microbiology Reviews 15 (3): 506–526. doi:10.1128/CMR.15.3.506-526.2002. ISSN 0893-8512.
- Mahoney FJ, Hoge CW, Farley TA, Barbaree JM, Breiman RF, Benson RF, McFarland LM (1 April 1992). "Communitywide Outbreak of Legionnaires' Disease Associated with a Grocery Store Mist Machine". Journal of Infectious Diseases 165 (4): 736–739. doi:10.1093/infdis/165.4.xxxx. PMID 1552203.
- Silivanch v. Celebrity Cruises, Inc., 171 F.Supp.2d 241 (S.D.N.Y. 2001) (plaintiff successfully sued cruise line and manufacturer of filter after catching disease on cruise)
- Winn WC Jr (1996). "Legionella". In Baron S et al. eds. Baron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1. Via NCBI Bookshelf.
- Woo AH, Goetz A, Yu VL (November 1992). "Transmission of Legionella by respiratory equipment and aerosol generating devices". Chest 102 (5): 1586–90. doi:10.1378/chest.102.5.1586. PMID 1424896.
- Cameron S, Roder D, Walker C, Feldheim J (1991). "Epidemiological characteristics of Legionella infection in South Australia: implications for disease control". Aust N Z J Med 21 (1): 65–70. PMID 2036080.
- Kohler R, Wheat LJ (September 1982). "Rapid diagnosis of pneumonia due to Legionella pneumophila serogroup 1". J. Infect. Dis. 146 (3): 444. doi:10.1093/infdis/146.3.444. PMID 7050258.
- Makin, Dr T (January 2008). "Legionella bacteria and solar pre-heating of water for domestic purposes" (PDF). UK Water Regulations Advisory Scheme Report: 4.
- "Legionnaire disease". Medline Plus. US National Library of Medicine. Retrieved 5 August 2015.
- Stout JE, Muder RR, Mietzner S, Wagener MM, Perri MB, DeRoos K, Goodrich D, Arnold W, Williamson T, Ruark O, Treadway C, Eckstein EC, Marshall D, Rafferty ME, Sarro K, Page J, Jenkins R, Oda G, Shimoda KJ, Zervos MJ, Bittner M, Camhi SL, Panwalker AP, Donskey CJ, Nguyen MH, Holodniy M, Yu VL (July 2007). "Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations". Infect Control Hosp Epidemiol 28 (7): 818–24. doi:10.1086/518754. PMID 17564984. as PDF
- "Legionnaire disease". Encyclopaedia Britannica. Retrieved 30 October 2013.
- McDade JE, Brenner DJ, Bozeman FM (1979). "Legionnaires' disease bacterium isolated in 1947". Ann. Intern. Med. 90 (4): 659–61. PMID 373548.
- Fraser DW, Tsai TR, Orenstein W, Parkin WE, Beecham HJ, Sharrar RG, Harris J, Mallison GF, Martin SM, McDade JE, Shepard CC, Brachman PS (1977). "Legionnaires' disease: description of an epidemic of pneumonia". N. Engl. J. Med. 297 (22): 1189–97. doi:10.1056/NEJM197712012972201. PMID 335244.
- "Legionellosis.". Massachusetts Department of Public Health. Bureau of Communicable Disease Control. Nov 2011. Retrieved 2012-11-12.
- Egan JR, Hall IM, Lemon DJ, Leach S (March 2011). "Modeling Legionnaires' disease outbreaks: estimating the timing of an aerosolized release using symptom-onset dates.". Epidemiology (Cambridge, Mass.) 22 (2): 188–98. doi:10.1097/ede.0b013e31820937c6. PMID 21242803.
- In Philadelphia 30 Years Ago, an Eruption of Illness and Fear, Lawrence K. Altman, The New York Times, August 1, 2006
- Arreigoso, Vera Lúcia. "Surto de legionella é o terceiro maior de sempre no mundo: 302 infetados e sete mortos". Jornal Expresso. Retrieved 12 November 2014.
- Remnick, Noah; Hu, Winnie (10 August 2015). "Hotel That Enlivened the Bronx Is Now a ‘Hot Spot’ for Legionnaires’". New York Times. Retrieved 13 August 2015.
- Yee, Vivian (2 August 2015). "Officials Seek Source of Legionnaires’ Outbreak in the Bronx". New York Times. Retrieved 6 August 2015.
- Remnick, Noah. "Legionnaires’ Disease Death Toll in Bronx Rises to 7". The New York Times. Retrieved 5 August 2015.